Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues
about
The reciprocal regulation between splicing and 3'-end processingBovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIBBovine papilloma virus-transformed cells contain multiple E2 proteins.Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiationRegulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycleTemporal usage of multiple promoters during the life cycle of human papillomavirus type 31b.Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidationDifferentiation-dependent chromatin rearrangement coincides with activation of human papillomavirus type 31 late gene expression.Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression.Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar wartsThe upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.Transcriptional regulation of the human papillomavirus-16 E6-E7 promoter by a keratinocyte-dependent enhancer, and by viral E2 trans-activator and repressor gene products: implications for cervical carcinogenesis.The bovine papillomavirus constitutive enhancer is essential for viral transformation, DNA replication, and the maintenance of latencyThe viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivoLife cycle heterogeneity in animal models of human papillomavirus-associated diseaseMessenger RNAs from the E1 region of bovine papillomavirus type 1 detected in virus-infected bovine cells.Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variationsClusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function.Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor: structural and functional analysis of new viral cDNAsMutational analysis of the 18-base-pair inverted repeat element at the bovine papillomavirus origin of replication: identification of critical sequences for E1 binding and in vivo replicationDifferentiation-specific alternative splicing of bovine papillomavirus late mRNAs.Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNASelection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressorA papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retentionThe specific DNA recognition sequence of the bovine papillomavirus E2 protein is an E2-dependent enhancerThe carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity.Analysis of HPV-1 E4 gene expression using epitope-defined antibodies.Sequence-specific and general transcriptional activation by the bovine papillomavirus-1 E2 trans-activator require an N-terminal amphipathic helix-containing E2 domain.The bovine papillomavirus P2443 promoter is E2 trans-responsive: evidence for E2 autoregulationAnalysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cellsStructural, functional, and protein binding analyses of bovine papillomavirus type 1 exonic splicing enhancersThe human immunodeficiency virus type 1 Rev protein and the Rev-responsive element counteract the effect of an inhibitory 5' splice site in a 3' untranslated regionMutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cellsThe genomes of the animal papillomaviruses European elk papillomavirus, deer papillomavirus, and reindeer papillomavirus contain a novel transforming gene (E9) near the early polyadenylation site.Identification and characterization of novel promoters in the genome of human papillomavirus type 18.Repression of bovine papillomavirus type 1 transcription by the E1 replication protein.Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promotersImportance of the bovine papillomavirus P2443 promoter in the regulation of E2 and E5 expression.Hierarchy of polyadenylation site usage by bovine papillomavirus in transformed mouse cells.
P2860
Q26750643-E34B46BA-17B7-4A41-BB4D-38997AE503B2Q33292465-7400D930-69F4-4516-B8A7-7B1887936228Q33638736-0FF377C2-9FDD-4374-907C-28E00970E0F7Q33645669-69AFE726-A919-412E-A0FE-31F2B376932EQ33648895-A3E077AD-3A65-4D75-ADDA-3E257094508CQ33783002-8B3E62F8-C44D-4C05-B994-8DFAE4395288Q33814170-6E6BC939-9E08-422B-AD1F-22E7243A64B7Q33839721-EBC471B5-100A-4B9B-85A1-2F2FC3D05D24Q33847281-9243CBEA-34F4-44E6-8A58-50544F00598BQ33853697-48583185-94F3-4B99-B411-DA98BB4BA7A0Q33905805-E62D6270-0D53-461A-9E2D-942BA62A86B2Q33929973-02BBF10D-67D8-465A-A543-57FDF589126BQ33929980-A889F13D-943D-40FF-8338-373F59205B0AQ33932448-B259E329-1A0C-4726-A488-8BCF2A1658C9Q34293109-52569114-E294-4BFD-BECB-A56E511AD220Q34348189-DACADF20-5118-4A88-9469-0D38913F917FQ34717843-5895338B-5FBF-4E47-8FDD-83EFA130DDADQ34770066-73D8C247-BE0A-4631-84A3-718147DADAE9Q35226050-E9588D6D-1B0B-4C04-AE56-E5DE0CCC72F6Q35409389-2E7249C9-9321-4834-A9B8-63CCE5AD8DB2Q35849102-22C74AD7-5A2E-4166-A160-1889F385735EQ35849203-6BC45FC6-CC6A-4958-BB3F-DAFE08452BC8Q35858861-73817787-C672-4D55-B79A-85214F656454Q35864749-97289375-183E-499E-921A-7E5BB1F85B38Q35882933-5DCA140F-C82E-4173-A573-F9C4F0017D42Q35977695-4901408A-E2AD-42F2-A7AA-EDA69C4FE924Q35977741-705956C9-E3D9-4F18-82F6-6398D39E0743Q35979296-9B9062C3-974E-4D54-990A-464F5AD9BB09Q36000905-1AF0395B-2637-417F-93E7-9521A3FB79DDQ36062091-AC521BDB-E9A6-4C1E-88CD-0528AAB061BCQ36295157-A3C419F8-75FA-4F71-9113-A078DBA0AB7EQ36548636-695E6800-E532-45B6-85D9-2FBDAD89B7FFQ36551242-A7A8379A-4C4F-43F8-A146-F118C11E9913Q36636113-46C2DAE6-9FB0-4776-B6C8-9C8E63896300Q36638250-C26CC4D2-3805-4E0D-9B48-56798F3A346EQ36650345-3E75F2F8-8C22-494E-AED4-BD8A44ACBD9FQ36651655-37CD7329-FD30-45DA-8824-7C150AABD8EAQ36652359-8706D2AD-CC97-4B7A-96DF-21715103DD1BQ36653942-5318B89A-9986-43E8-9BB5-9C19462F52FBQ36655698-5403F633-DC4C-4352-B216-23E6AB66D97A
P2860
Differential promoter utilization by the bovine papillomavirus in transformed cells and productively infected wart tissues
description
1987 nî lūn-bûn
@nan
1987 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
name
Differential promoter utilizat ...... uctively infected wart tissues
@ast
Differential promoter utilizat ...... uctively infected wart tissues
@en
type
label
Differential promoter utilizat ...... uctively infected wart tissues
@ast
Differential promoter utilizat ...... uctively infected wart tissues
@en
prefLabel
Differential promoter utilizat ...... uctively infected wart tissues
@ast
Differential promoter utilizat ...... uctively infected wart tissues
@en
P2860
P1433
P1476
Differential promoter utilizat ...... uctively infected wart tissues
@en
P2093
P2860
P304
P356
10.1002/J.1460-2075.1987.TB04855.X
P407
P577
1987-04-01T00:00:00Z